Phytochemical Name : Paeoniflorin

Properties Information
PhytoCAT-ID PhytoCAT-736
Phytochemical name or plant extracts Paeoniflorin
PMID 27175085
Literature evidence This finding provides evidence that PF can serve as a therapeutic agent for the treatment of breast cancer.
IUPAC name [(1R,2S,3R,5R,6R,8S)-6-hydroxy-8-methyl-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-9,10-dioxatetracyclo[4.3.1.02,5.03,8]decan-2-yl]methyl benzoate
Phytochemicals’ class or type of plant extracts Monoterpene
Source of phytochemicals or plant Extracts Paeonia lactiflora
Geographical availability Amur, China North-Central, China South-Central, China Southeast, Chita, Inner Mongolia, Khabarovsk, Manchuria, Mongolia, Primorye
Plant parts Root
Other cancers Breast cancer
Target gene or protein PI3K, AKT, HIF-1α, NOTCH‑1 and HES‑1
Gene or Protein evidence Furthermore, PF prevented hypoxia-induced expression of phosphorylated PI3K and Akt in MDA-MB-231 cells. In conclusion, PF prevented hypoxia-induced EMT in breast cancer cells by inhibiting HIF-1α expression via modulation of PI3K/Akt signaling pathway. NOTCH‑1 and HES‑1 protein levels demonstrated a similar trend to the mRNA levels, whereby an increase in the concentration of PF was associated with a decrease in NOTCH‑1 and HES‑1 protein expression levels.
Target pathways PI3K/Akt signaling pathway, NOTCH‑1 signaling pathway
IC50 NA
Potency The results presented in this study demonstrate that PF blocks the migration and invasion of breast cancer cells by repressing EMT under hypoxic conditions. PF also significantly attenuated the hypoxia-induced increase in HIF-1α level.
Cell line/ mice model MDA-MB-231
Additional information  This finding provides evidence that PF can serve as a therapeutic agent for the treatment of breast cancer.
PubChem ID 442534
Additional PMIDs 31858611 27175085 29115554
Additional sources of information https://powo.science.kew.org/taxon/urn:lsid:ipni.org:names:711802-1
Safety NA